Serum N-terminal pro-atrial natriuretic factor 1-98 before and during thyroxine replacement therapy in severe hypothyroidism

Thyroid

Volumn 7, Issue 3, 1997, Pages 415-419

  Bernstein, Roger ^a,b,d   Midtbø, Kjell ^a   Urdal, Petter ^a   Mørkrid, Lars ^c   Smith, Gunnar ^a   Müller, Carl ^a   Bjøro, Trine ^b   Haug, Egil ^b  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b AKER UNIVERSITY HOSPITAL   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d NONE   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; THYROXINE;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; CLINICAL ARTICLE; DOSE RESPONSE; DRUG BLOOD LEVEL; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART PERFORMANCE; HEMODYNAMICS; HUMAN; HYPOTHYROIDISM; MALE; PERICARDIAL EFFUSION; PRIORITY JOURNAL; SUBSTITUTION THERAPY; THYROID HORMONE SYNTHESIS;

EID: 0030747831     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1997.7.415     Document Type: Article

References (26)

1. Vesely DL, Norris JS, Walters JM, Jespersen RR, Baeyens DA 1987 Atrial natriuretic prohormone peptides 1-30, 31-67, and 79-98 vasodilate the aorta. Biochem Biophys Res Commun 148:1540-1548.
2. Zimmerman RS, Gharib H, Zimmerman D, Heublein D, Burnett JR Jr 1987 Atrial natriuretic peptide in hypothyroidism. J Clin Endocrinol Metab 64:353-355.
3. Kohno M, Murakawa K, Yasumari K, Nishizawa Y, Mori H, Takedea T 1987 Circulating atrial natriuretic peptides in hyperthyroidism and hypothyroidism. Am J Med 83:648-652.
4. Vesely DL, Winters CJ, Sallman AL 1989 Prohormone atrial natriuretic peptides 1-30 and 31-67 increase in hyperthyroidism and decrease in hypothyroidism. Am J Med Sci 297:209-251.
5. Ota K, Kimura T, Sakurada T, Shoji M, Inoue M, Sato K, Ohta M, Yamamoto T, Funuyu T, Yoshida K, Abe K 1994 Effects of an acute water load on plasma ANP and AVP, and renal water handling in hypothyroidism: Comparison of before and after L-thyroxine treatment. Endocr J 41:99-105.
6. Weissel M, Pantzengruber C, Hartter E, Ludvik B, Woloszczuk W 1986 Thyroid hormones and pericardial effusion may influence plasma levels of atrial natriuretic peptide (ANP) in humans. Klin Wochenschr 64:(suppl 6):93-96.
7. Yamaji T, Ishibashi M, Takaku F, Sato F, Kamoi K 1988 Plasma atrial natriuretic peptide in states of altered thyroid function. Endocrinol Japan 35:243-348.
8. Rolandi E, Santaniello B, Bagnasco M, Cataldi A, Garibaldi C, Fracheschini R, Barreca T 1992 Thyroid hormones and atrial natriuretic hormone secretion: Study in hyper- and hypothyroid patients. Acta Endocrinol 127:23-26.
9. Winters CJ, Sallman AL, Baker BJ, Meadows J, Rico DM, Vesely DL 1989 The N-terminus and a 4,000-MW peptide from the midportion of the N-terminus of the atrial natriuretic factor prohormone each circulate in humans and increase in congestive heart failure. Circulation 80:438-449.
10. Edwards B, Zimmerman R, Schwab T, Heublein D, Burnett J 1988 Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor. Circ Res 62:191-195.
11. Dillmann WH 1991 The cardiovascular system in hypothyroidism. In: Braverman LE, Utiger RD (eds) Werner and Ingbar's The Thyroid, 6th ed. J.B. Lippincott Co, Philadelphia, pp. 1004-1005.
12. Gower WR Jr, Chiou S, Skolnik KA, Vesely DL 1994 Molecular forms of circulating atrial natriuretic peptides in human plasma and their metabolites. Peptides 15:861-867.
13. Bernstein R, Midtbø K, Smith G, Müller C, Haug E, Holme I, Hertzenberg L 1995 Incidence of hypertrophic cardiomyopathy in hypothyroidism. Thyroid 5:277-281.
14. Moleman P, Borstrok JJ, Kraak JC 1982 Application of a sodium gradient in dynamic cation-exchange systems for rapid analysis by high-performance liquid chromatography and electrochemical detection of urinary catecholamines after a single purification step with aluminum oxide. J Chromatogr Biomed Appl 232(2):418-423.
15. Sundsfjord JA, Thibault G, Larochelle P, Cantin M 1988 Identification and plasma concentrations of the N-terminal fragment of proatrial natriuretic factor in man. J Clin Endocrinol Metab 66:605-610.
16. Hall C, Aaberge L, Stokke O 1995 In vitro stability of N-terminal proatrial natriuretic factor in unfrozen samples: An important prerequisite for its use as a biochemical parameter of atrial pressure in clinical routine. Circulation 91:911.
17. 2-terminal fragment of rat pro-atrial natriuretic factor in the circulation: identification, radioimmunoassay and half-life. Peptides 9:47-53.
18. Gardener DG, Gertz BJ, Hane S 1987 Thyroid hormone increases rat atrial natriuretic peptide messenger ribonucleic acid accumulation in vivo and in vitro. J Mol Endocrinol 1:260-265.
19. Christensen NJ 1972 Increased levels of plasma noradrenaline in hypothyroidism. J Clin Endocrinol Metab 35:359-363.
20. Coulombe P, Dussault JH, Walker P 1977 Catecholamine metabolism in thyroid disease. II. norepinephrine secretion rate in hyperthyroidism and hypothyroidism. J Clin Endocrinol Metab 44:1185-1189.
21. Uehlinger DE, Weidmann P, Gnaedinger MP, Shaw S, Lang RE 1986 Depressor effects and release of atrial natriuretic peptide during norepinephrine or angiotensin II infusion in man. J Clin Endocrinol Metab 63:669-674.
22. Jespersen B, Dam Jensen J, Brock A, Bjerregaard Pedersen E 1992 Atrial natriuretic peptide and parathyroid hormone (1-84) in relation to noradrenaline changes in blood pressure in uremic and healthy subjects. Scand J Urol Nephrol 26:269-274.
23. Chu A, Morris KG, Kuehl WD, Cusma J, Navetta F, Cobb FR 1989 Effects of atrial natriuretic peptide on the coronary arterial vasculature in humans. Circulation 80:1627-1635.
24. Rosenthal AD, Moran M, Herrmann HC 1990 Coronary hemodynamic effects of atrial natriuretic peptide in humans. J Am Coll Cardiol 16:1107-1113.
25. Bernstein R, Müller C, Midtbø K, Smith G, Haug E, Hertzenberg L 1995 Silent myocardial ischemia in hypothyroidism. Thyroid 5:443-447.
26. Bernstein R, Müller C, Midtbø K, Haug E, Nakken KF, Hertzenberg L, Kjørstad KE 1991 Cardiac left ventricular function before and during early thyroxine treatment in severe hypothyroidism. J Intern Med 230:493-500.